Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?

Newly diagnosed high grade serous epithelial ovarian cancer (EOC) patients are treated with radical surgery followed by adjuvant platinum and taxane combination chemotherapy. In EOC patients where upfront surgery is contraindicated for medical reasons (e.g., comorbidities or poor performance status)...

Full description

Saved in:
Bibliographic Details
Published in:Ann Transl Med
Main Authors: Moschetta, Michele, Boussios, Stergios, Rassy, Elie, Samartzis, Eleftherios P., Funingana, Gabriel, Uccello, Mario
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2020
Subjects:
Review Article on Ovarian Cancer: State of the Art and Perspectives of Clinical Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812234/
https://ncbi.nlm.nih.gov/pubmed/33490222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-1683
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items